Om

Alcon N 2.Linie is a Swiss pharmaceutical and medical devices company specializing in eye care solutions. The company develops, manufactures, and markets a comprehensive portfolio of products designed to address various ophthalmological conditions and needs. Its offerings include prescription medications for eye diseases, surgical devices for ophthalmic procedures, and over-the-counter eye care products for consumers. Alcon serves multiple market segments including hospitals, surgical centers, ophthalmology clinics, optometry practices, and retail channels. The company operates globally, providing solutions for conditions such as dry eye disease, glaucoma, cataracts, and retinal disorders. As a prominent player in the eye care industry, Alcon plays a significant role in advancing treatment options and improving vision outcomes for patients worldwide. The company combines innovation in pharmaceutical development with advances in surgical technology to address diverse eye health needs across different patient populations and healthcare settings.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ALCON MED ENDAVU: Køb Alcon ($ALCE) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Alcon, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.